The outcome of chronic dialysis in infants and toddlers - Advantages and drawbacks of haemodialysis (Nephrology Dialysis Transplantation (2007) DOI: 10.1093/ndt/gfm734);The outcome of chronic dialysis in infants and toddlers - Advantages and drawbacks of haemodialysis

Nephrology Dialysis Transplantation

Volumn 23, Issue 4, 2008, Pages 1336-1345

  Feinstein, Sofia ^a   Rinat, Choni ^a   Becker Cohen, Rachel ^a   Ben Shalom, Efrat ^a   Schwartz, Shepard B ^a   Frishberg, Yaacov ^a,b  

^a HEBREW UNIVERSITY   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

ESRD; Haemodialysis; Infants; Outcome; Peritoneal dialysis; Toddlers

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; SUCROSE;

ANEMIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; HEMODIALYSIS; HUMAN; INFANT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RESIDUAL VOLUME; TREATMENT OUTCOME; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; METHODOLOGY; NEWBORN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RENAL REPLACEMENT THERAPY;

CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; OUTCOME ASSESSMENT (HEALTH CARE); RENAL DIALYSIS;

EID: 42949106654     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn219     Document Type: Erratum

References (30)

1. Geary DF. Attitudes of pediatric nephrologists to management of end-stage renal disease in infants. J Pediatr 1998; 133: 154-156
2. Bunchman TE. Chronic dialysis in the infant less than 1 year of age. Pediatr Nephrol 1995; 9: S18-S22
3. Warady BA, Hebert D, Sullivan EK et al. Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1997; 11: 49-64
4. Al-Hermi BE, Al-Sarah K, Secker D et al. Hemodialysis for end-stage renal disease in children weighting less than 10 kg. Pediatr Nephrol 1999; 13: 401-403
5. Wood EG, Matthew H, Briscoe MD et al. Risk factors for mortality in infants and young children on dialysis. Am J Kidney Dis 2001; 37: 573-579
6. Leonard MB, Donaldson LA, Ho M et al. A prospective cohort study of incident maintenance dialysis in children: an NAPRTC study. Kidney Int 2003; 63: 744-755
7. Verrina E, Edefonti A, Gianoglio B et al. A multicenter experience on patient and technique survival in children on chronic dialysis. Pediatr Nephrol 2004;19: 82-90
8. Shroff R, Rees L, Trompeter R et al. Long term outcome of chronic dialysis in children. Pediatric Nephrol 2006; 21: 257-264
9. Carrey WA, Talley LI, Sehring SA et al. Outcomes of dialysis initiated during the neonatal period for treatment of end stage renal disease: a North American Pediatric Renal Trials and Collaborative Studies special analysis. Pediatrics 2007; 119: e468-e473
10. Groothoff JW, Mariken P, Gruppen MP et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 2002; 61: 621-629
11. Coulthard MG, Cosier J. Outcome of reaching end stage renal failure in children under 2 years of age. Arch Dis Child 2002; 87: 511-517
12. Ehrich JHH, Rizzoni G, Brunner FP et al. Renal replacement therapy for end-stage renal failure before 2 years of age. Nephrol Dial Transplant 1992; 7: 1171-1177
13. Ledermann SE, Scanes ME, Fernando ON et al. Long-term outcome of peritoneal dialysis in infants. J Pediatr 2000; 136: 24-29
14. Shroff R, Wright E et al. Chronic hemodialysis in infants and children under 2 years of age. Pediat Nephrol 2003; 18: 378-383
15. Ellis EN, Pearson D, Champion B Outcome of infants on chronic peritoneal dialysis. Adv Perit Dial 1995; 11: 266-269
16. Sinnassamy P, Andre JL, Treize G et al. Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study. Arch Fr Pediatr 1993; 50: 201-208
17. Van Damme-Lombaerts R, Broyer M, Businger J et al. A study of recombinant human erythropoietin in the treatment of anemia of chronic renal failure in children on haemodialysis. Pediatr Nephrol 1994; 8: 338-342
18. Brandt JR, Avner ED, Hickman RO et al. Safety and efficacy of erythropoietin in children with chronic renal failure. Pediatr Nephrol 1999; 13: 143-147
19. Seeherunvong W, Rubio L, Abitbol CL et al. Identification of poor responders to erythropoietin among children undergoing hemodialysis. J Pediatr 2001; 138: 710-714
20. National Kidney Foundation. K/DOQI Clinical practice guidelines for anemia of chronic kidney disease, 2000. Am J Kidney Dis 2001; 37: S1182-S238
21. Chavers BM, Roberts TL, Herzog A et al. Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients. Kidney Int 2004; 65: 266-273
22. Carnielli V, Montini G, Da Riol R et al. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992; 121: 98-102
23. Halperin D, Felix M, Wacker P et al. Recombinant human erythropoietin in the treatment of infants with anemia of prematurity. Eur J Pediatr 1992; 151: 661-667
24. Messer J, Haddad J, Donato L et al. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993; 92: 519-523
25. Shannon KM, Keith III JF, Mentzer WC et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterminfants. Pediatrics 1995; 95: 1-8
26. Feusner J, Hasting C. Recombinant human erythropoietin in pediatric oncology: a review. Med Pediatr Oncol 2002; 39: 463-468
27. Patton J, Kuzur M, Liggett W et al. Epoetin Alfa 60,000U once weekly followed by 120,000U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy. Oncologist 2004; 9: 90-96
28. Cournoyer D, Toffelmire EB, Wells GA et al. Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk. J Am Soc Nephrol 2004; 15: 2728-2734
29. Kharagjitsingh AV, Korevaar JC, Vandenbroucke JP et al. Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients. Kidney Int 2005; 68: 1215-1222
30. Brown KR, Carter WJ, Lombardi GE. Recombinant erythropoietin overdose. Am J Emerg Med 1993; 11: 619-621